XTX Topco »

Achilles Therapeutics shares owned by XTX Topco

Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by XTX Topco from 13F filings

Historical chart of XTX Topco investment in Achilles Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Achilles Therapeutics held by XTX Topco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achilles Therapeutics by XTX Topco

Quarter filed Position value Share count Share price at filing
2025-03-31 $58k 39k 1.48
2024-12-31 $31k 27k 1.14
2024-06-30 $42k 52k 0.82
2024-03-31 $19k 15k 1.25
2023-09-30 $19k 21k 0.91

More positions owned by XTX Topco

NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Johnson & Johnson (JNJ)
Cme (CME)
Thermo Fisher Scientific (TMO)
Cisco Systems (CSCO)
Bristol Myers Squibb (BMY)
Enbridge (ENB)
American Tower Reit (AMT)
Us Bancorp Del Com New (USB)
American Intl Group Com New (AIG)
TJX Companies (TJX)
Southern Company (SO)
Stellantis SHS (STLA)
Ares Management Corporation Cl A Com Stk (ARES)

View all positions for XTX Topco

Top funds holding Achilles Therapeutics

Rhumbline Advisers
GAMMA Investing

View all funds holding Achilles Therapeutics